VI4
-
November 15, 2023
Novel C. diff structures are required for infection, offer new therapeutic targets
Vanderbilt research discovers that iron storage “spheres” inside the bacterium C. diff — the leading cause of hospital-acquired infections — are important for infection in an animal model and could offer new targets for antibacterial drugs. -
September 29, 2023
Educational event zooms in on complex world of microbes
More than 100 children and their families attended the sixth annual MEGAMicrobe community science recently at Gower Elementary School in Nashville. -
July 28, 2023
VI4 Artist-in-Residence exhibition opens Aug. 7
The Vanderbilt Institute for Infection, Immunology and Inflammation Artist-in-Residence Program (VI4-AiR) invites the public to the opening celebration of its “Molecular Muse” exhibition Aug. 7 at the Vanderbilt Fine Arts Gallery. -
April 20, 2023
Study details RNA editing in virus-infected cancer cells
Vanderbilt researchers detail the landscape of RNA editing — a form of RNA modification — in primary effusion lymphoma cells during Kaposi’s sarcoma-associated herpesvirus infection and identify an edited viral microRNA that is critical for infection. -
March 23, 2023
Mathers Foundation award supports study of bacterial physiology
Vanderbilt's Wenhan Zhu, PhD, has received a three-year award from the G. Harold and Leila Y. Mathers Foundation to support his research that aims to answer a fundamental question about bacterial physiology and engineer probiotics to improve gut inflammatory diseases. -
March 23, 2023
E. coli uses serine to abide acidity
Vanderbilt researchers have discovered another acid resistance mechanism for UTI-causing E. coli, laying the foundation for targeted antibacterial therapies. -
February 20, 2023
Probing hellbender health
Understanding how hellbenders — large, fully aquatic salamanders — fight fungal pathogens and disease is important for protecting these unique stream predators; Vanderbilt researchers add new insights.